Drug Shortage Report for ZANTAC
| Report ID | 2745 |
| Drug Identification Number | 02212331 |
| Brand name | ZANTAC |
| Common or Proper name | Ranitidine tablets |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RANITIDINE |
| Strength(s) | 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100's |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2016-10-04 |
| Estimated end date | |
| Actual end date | 2017-09-14 |
| Shortage status | Resolved |
| Updated date | 2020-02-27 |
| Company comments | This product has been discontinued. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-02-27 | French | Compare |
| v7 | 2020-02-27 | English | Compare |
| v6 | 2017-09-18 | French | Compare |
| v5 | 2017-09-18 | English | Compare |
| v4 | 2017-03-17 | French | Compare |
| v3 | 2017-03-17 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v1 | 2017-03-14 | English | Compare |
Showing 1 to 8 of 8